or
forgot password

    • cancer clinical trials in birmingham, AL

    • The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
    Millennium Therapeutics & Research
    Birmingham, Alabama 35205
    Prostate Cancer
    VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
    University of Alabama
    Birmingham, Alabama
    Mantle Cell Lymphoma
    Bortezomib With or Without Docetaxel in Treating Patients With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Lung Cancer
    Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
    Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
    Birmingham, Alabama 35294
    Cervical Cancer
    Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Sarcoma
    Endometrial Biopsy in Infertile Patients
    University of Alabama
    Birmingham, Alabama
    Infertility
    Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer
    GSK Investigational Site
    Birmingham, Alabama 35209
    Non-Small-Cell Lung Cancer, Lung Cancer, Non-Small Cell
    Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Lung Cancer
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Metastatic Cancer, Sarcoma
    Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Lymphoproliferative Disorder
    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Vulvar Cancer
    Treatment of Infertility in Women With Polycystic Ovary Syndrome
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Polycystic Ovary Syndrome, Infertility, Pregnancy
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    Birmingham Hematology and Oncology
    Birmingham, Alabama 35235
    Prostate Cancer, Hormone Refractory Prostate Cancer
    Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Non-Hodgkin's Lymphoma
    A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
    Birmingham, Alabama
    Carcinoma, Non-Small-Cell Lung
    Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Leukemia
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
    Birmingham, Alabama 35294
    Lymphoma
    A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care
    University of Alabama School of Medicine
    Birmingham, Alabama 35294
    Myelodysplastic Syndromes
    Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Endometrial Cancer
    Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Lymphoma
    A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer
    GSK Investigational Site
    Birmingham, Alabama 35209
    Non-Small-Cell Lung Cancer, Lung Cancer, Non-Small Cell
    Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma
    Pfizer Investigational Site
    Birmingham, Alabama 35205
    Lymphoma, B-Cell
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Lymphoma, Infection, Leukemia
    Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Multiple Myeloma, Plasma Cell Neoplasm
    Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
    University of Alabama
    Birmingham, Alabama
    Neurofibromatosis 1, Neurofibroma, Plexiform
    The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
    University of Alabama at Birmingham - Division of Neurosurgery
    Birmingham, Alabama 35294-3410
    Glioblastoma Multiforme
    DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Unspecified Adult Solid Tumor, Protocol Specific
    Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Brain and Central Nervous System Tumors
    Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Lung Cancer
    Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)
    University of Alabama
    Birmingham, Alabama
    Acute Myeloid Leukemia
    Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma
    University of Alabama, Birmingham
    Birmingham, Alabama 35233
    Anaplastic Large-Cell Lymphoma
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    UAB CCC Clinical Studies Unit
    Department of Veterans Affairs Medical Center
    Non Small Cell Lung Carcinoma
    Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Acute Myeloid Leukemia
    A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma
    ImClone Investigational Site
    Birmingham, Alabama 35233
    Ovarian Cancer
    hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Neuroblastoma
    Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Breast Cancer
    Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
    University of Alabama, Birmingham
    Birmingham, Alabama 35233
    Ovarian Cancer, Primary Peritoneal Carcinoma
    Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer

    Birmingham, Alabama 35294
    Breast Neoplasms, Neoplasm Metastasis
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Brain Tumor, Central Nervous System Tumor
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Endometrial Cancer
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Birmingham Hematology Oncology Associates

    Trial Locations
    Birmingham Hematology Oncology Associates
    Birmingham Hematology and Oncology Associates, LLC
    Non-Small Cell Lung Cancer
    Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Cervical Cancer
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    Birmingham Hematology and Oncology Associates, LLC

    Trial Locations
    Birmingham Hematology and Oncology Associates, LLC
    Birmingham Hematology and Oncology Associates
    Carcinoma, Non-Small-Cell Lung
    T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Actinic Keratosis, Basal Cell Carcinoma of the Skin, Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin
    XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors
    University of Alabama at Birmingham Comprehensive Cancer Center
    Birmingham, Alabama 35294-3300
    Biliary Tract Cancer
    Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Glioblastoma Multiforme
    Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Birmingham, Alabama 35294
    Non Small Cell Lung Cancer
    Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy
    Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
    Birmingham, Alabama 35294
    Gestational Trophoblastic Tumor
    A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Univ. of Alabama at Birmingham
    Birmingham, Alabama 35233
    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
    Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
    GSK Investigational Site
    Birmingham, Alabama 35209
    Ovarian Cancer
    Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma
    Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
    Birmingham, Alabama 35294
    Lymphoma
    Epratuzumab and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Recurrent Childhood Acute Lymphoblastic Leukemia